Hims & Hers Health

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-18 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Hims & Hers Health, Inc. (HIMS) CIK: 0001773751 --- Reporting Owner --- Name: Okupe Oluyemi CIK: 0001907056 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-05-18 | Code: M (Exercise of derivative) Shares: +7,950 | Price: $5.01 Total Value: $39,829.50 Shares Owned After: 270,904 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [Transaction #2] Security: Class A Common Stock Date: 2026-05-18 | Code: S (Open market sale) Shares: -7,950 | Price: $23.64 Total Value: $187,915.74 Shares Owned After: 262,954 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [F2] Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $23.55- $23.80. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (right to buy) Date: 2026-05-18 | Code: M (Exercise of derivative) Shares: -7,950 | Price: $0.00 Exercisable: N/A | Expires: 2032-02-23 Shares Owned After: 115,900 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [F3] The stock options are fully vested and exercisable. --- Holdings --- [Holding #1] Security: Class A Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $23.55- $23.80. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3: The stock options are fully vested and exercisable. --- Signature --- /s/ /s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe (2026-05-19)